The Ogden Memo (2009)

Federal-state conflict before 2009

By 2009, thirteen U.S. states had enacted medical cannabis laws, beginning with California's Proposition 215 in 1996. Cannabis remained a Schedule I controlled substance under federal law, and the Supreme Court had affirmed in Gonzales v. Raich (2005) that federal authorities retained constitutional power to prosecute even purely intrastate medical use.

During the Bush administration (2001–2009), the U.S. Attorneys' offices and the DEA conducted high-profile raids and prosecutions targeting California cultivation and dispensary operations ^[1]. On the 2008 campaign trail, candidate Barack Obama signaled that he would not use federal resources to circumvent state medical cannabis laws ^[2]. The Ogden Memo emerged as the first written attempt to formalize that political commitment into DOJ prosecutorial guidance.

What the memo actually said

On October 19, 2009, Deputy Attorney General David W. Ogden issued a three-page memorandum titled Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana to U.S. Attorneys in states with medical cannabis laws ^[3].

Key statements:

• Federal prosecution of marijuana offenses remained 'a core priority' of the Department of Justice.
• However, 'as a general matter, pursuit of these priorities should not focus federal resources in your States on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana.'
• The memo identified factors that would warrant federal attention: sales to minors, use of firearms, violence, ties to organized crime or other criminal enterprises, money laundering, quantities inconsistent with personal medical use, and evidence that state law was being used as cover for non-medical trafficking.
• The memo explicitly stated it did 'not legalize marijuana' and conferred 'no legal defense to any defendant' ^[3].

In plain terms: The memo offered prosecutorial discretion favoring low-priority enforcement for patients and caregivers in clear compliance with state law—not legal protection, not amnesty, and not authorization for commercial sale.

How the myth developed

Cannabis industry publications and state-level entrepreneurs rapidly reinterpreted the Ogden Memo as a federal stand-down order. Dispensary counts in California, Colorado, and Montana climbed sharply from 2010 onward, and openly commercial cultivation operations expanded ^[4]. The phrase 'Ogden Memo protections' began appearing in investor discussions and business planning documents Weak / limited.

This reading distorted the memo's scope. The document addressed patients and caregivers acting in 'clear and unambiguous compliance' with state law—not the commercial dispensary industry, which most state statutes did not explicitly authorize. Colorado and Washington had no legal framework for retail cannabis until voters approved adult-use legalization in November 2012. California's medical law did not authorize storefront retail; the state's dispensary industry operated in a regulatory gray zone ^[4].

The persistent claim that the Ogden Memo 'legalized medical marijuana federally' or 'protected dispensaries' is false Strong evidence. The text does neither ^[3].

The 2011 Cole clarification

By 2011, federal prosecutors in California, Washington, Montana, and other states were issuing threat letters to landlords of dispensaries and conducting raids and seizures. On June 29, 2011, Deputy Attorney General James M. Cole issued a follow-up memo clarifying that the Ogden Memo had been 'never intended to shield' commercial cultivation, distribution, and dispensary operations from federal enforcement ^[6].

The 2011 Cole Memo explicitly stated that large-scale, for-profit cannabis operations—regardless of state medical authorization—remained subject to federal prosecution. Ogden had become politically toxic within the DOJ, and the Cole clarification was widely understood as the effective end of the 'Ogden era' in federal cannabis policy ^[5].

A second Cole Memo in August 2013—issued after Colorado and Washington voters had approved adult-use legalization in November 2012—articulated eight federal enforcement priorities that would govern DOJ marijuana policy through 2017 ^[7]. Attorney General Jeff Sessions rescinded both Cole memos in January 2018 ^[8].

Statutory protections and continuity

The vulnerability of prosecutorial guidance became apparent: a change in administration could reverse it at any time. By 2014, Congress had begun enacting appropriations riders protecting certain state cannabis programs from federal prosecution. The Rohrabacher–Farr Amendment, first included in the Consolidated and Further Continuing Appropriations Act of 2014 (and renewed thereafter), prohibited the Department of Justice from using federal funds to prosecute individuals engaged in conduct authorized by state medical cannabis law ^[9].

This statutory rider—unlike a memo—could not be rescinded by the Attorney General. When Sessions withdrew the Cole Memos in January 2018, the Rohrabacher–Blumenauer rider (renamed following the 2018 congressional elections) remained in place, continuing to restrict federal prosecution of state-authorized medical cannabis activities ^[8][9]. The lesson reformers drew: prosecutorial discretion is always temporary; only law endures.

Historical significance

The Ogden Memo matters to cannabis policy history for three reasons:

First formal federal forbearance. It was the first written acknowledgment by the Department of Justice that state medical cannabis programs existed and that patients in compliance with them ranked low on the federal enforcement priority ladder Strong evidence. Earlier administrations had not issued comparable guidance ^[3].

Template for future DOJ guidance. The structure of the memo—listing enforcement priorities, framing discretion, and including an explicit non-legalization disclaimer—became the model for the Cole memos and influenced the Financial Crimes Enforcement Network's 2014 banking guidance on cannabis-related businesses ^[7][10].

Cautionary tale about guidance vs. law. The rapid reversal from Ogden (2009) to Cole clarification (2011) to Sessions rescission (2018) demonstrated that internal prosecutorial memos are not law and cannot survive a change in administration policy. This history is now cited by cannabis reform advocates as the primary argument for statutory protections rather than reliance on executive discretion Strong evidence.

Sources

How this page was made

Related

• Cannabis Policy Under the Obama Administration — Federal prosecutorial discretion memos that created a policy shift without legislative ref...
• Cole Memo Rescission (2018) — Jeff Sessions ended cannabis prosecutorial guidance on January 4, 2018—but enforcement did...
• Wilkinson Memo and Tribal Cannabis Sovereignty — Federal guidance on Native American tribal authority over cannabis cultivation, sales, and...